ONCOSPHERIX
OncoSpherix is committed to improving the quality of life and survival in people whose cancers cannot be cured by the standard of care. Most tumors grow faster than their blood supplies, which leads to regions where tumor cells are starved of oxygen, a situation known as hypoxia. Rather than being killed by the hypoxia, tumor cells fight back through the expression of master regulatory proteins called hypoxia inducible factors.
ONCOSPHERIX
Industry:
Clinical Trials Health Care Medical
Founded:
2018-01-01
Address:
Gaussan, Midi-Pyrenees, France
Country:
France
Website Url:
http://www.Oncospherix.com
Total Employee:
51+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
117.42 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon WordPress Mobile Non Scaleable Content Euro WordPress 6.0 GStatic Google Static Content
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
ConvaTec
ConvaTec specializes in the development, manufacture, distribution of single-use devices to hospitals and healthcare sectors.
Genetron Health
Genetron Health is a world-leading expert in precision medicine.
heartbeat medical
Heartbeat collects the most important data point in healthcare: quality of life (PROMs) and turns it into Real World Evidence (RWE)
Obeo Health
Using the power of data to get more from your healthcare
Spire Healthcare
Spire Healthcare is a hospital group providing inpatient and outpatient care, diagnostics, and primary care.
Investors List
Georgia Research Alliance
Georgia Research Alliance investment in Grant - Oncospherix
Georgia Research Alliance
Georgia Research Alliance investment in Grant - Oncospherix
Georgia Research Alliance
Georgia Research Alliance investment in Grant - Oncospherix
Official Site Inspections
http://www.Oncospherix.com
- Host name: box2059.bluehost.com
- IP address: 67.222.39.83
- Location: Provo United States
- Latitude: 40.2342
- Longitude: -111.6442
- Metro Code: 770
- Timezone: America/Denver
- Postal: 84606
More informations about "Oncospherix"
OncoSpherix | Advanced Drugs for Advanced Cancer
First-in-class small molecules that disable adaptive responses in many types of cancer. OncoSpherix’s lead compounds disrupt the activation of HIFs by preventing the recruitment of …See details»
Oncospherix - Funding, Financials, Valuation & Investors
Oncospherix is the culmination of a multi-year research program for cancer. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log In. Log In. Experience the …See details»
OncoSpherix - LinkedIn
OncoSpherix, Inc., based in Atlanta, Ga, is a pre-clinical stage oncology drug development company that is advancing a proprietary platform of first-in-class small molecule therapeutics …See details»
Pioneering company - OncoSpherix
The team at OncoSpherix is committed to addressing some of cancer’s toughest challenges: cancers that are not cured by the current best-available treatments. Company History …See details»
Oncospherix - Contacts, Employees, Board Members, Advisors
Oncospherix is the culmination of a multi-year research program for cancer. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log In. Log In. Experience the …See details»
OncoSpherix - Products, Competitors, Financials, Employees ...
OncoSpherix focuses on the development of advanced drugs for the treatment of various forms of cancer within the pharmaceutical industry. Use the CB Insights Platform to explore …See details»
Kenneth Moch - OncoSpherix
Kenneth Moch joins the OncoSpherix team as Special Advisor to the CEO: “It is a privilege to have Ken Moch serve as my advisor as we build OncoSpherix into a successful drug development company that is advancing agents that should …See details»
OncoSpherix | Science Company | Labroots
OncoSpherix, Inc., based in Atlanta, Ga, is a pre-clinical stage oncology drug development company that is advancing a proprietary platform of first-in-class...See details»
Oncospherix - Overview, News & Similar companies - ZoomInfo
Who is Oncospherix. OncoSpherix is a pre-clinical stage oncology drug development company that is advancing a novel, diversified and risk-mitigated proprietary platfor m of small molecule …See details»
OncoSpherix, Inc. - VentureRadar
OncoSpherix is a pre-clinical stage oncology drug development company that is advancing a platform of small molecule therapeutics designed to treat many types of advanced cancer by …See details»
Oncospherix - Updates, News, Events, Signals & Triggers
Oncospherix is engaged in the research and development of solid forms of an inhibitor of HIF (Hypoxia-Inducible Factor) and methods of using these forms. This work is part of their …See details»
Oncospherix - Drug pipelines, Patents, Clinical trials - Synapse
Explore Oncospherix with its drug pipeline, therapeutic area, technology platform, 1 news, Disease Domain:Neoplasms, Technology Platform:Chemical drugs, Drug:64B. ... The statistics …See details»
OncoSpherix - Georgia State University Startups - University …
OncoSpherix was founded with the goal of making a difference in the lives of the more than 600,000 cancer patients who die from unresectable solid tumors in the U.S. each year.. …See details»
OncoSpherix
OncoSpherix is a biotechnology company that is developing drug therapies to treat cancer. Most cancerous tumors have spots where the cancer cells don’t receive much blood, depriving them …See details»
Collaborating with OncoSpherix
OncoSpherix appointed Dr. Robert Scott to the Board of Directors in January 2021. Dr. Scott has held leadership positions in global Pharma for over thirty years, most recently as the Chief …See details»
Oncospherix - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Organization. Oncospherix . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 2. Monthly Visits 372. …See details»
Oncospherix - Advanced Drugs for Advanced Cancer - YouTube
May 16, 2020 Short Overview by Dr. Margaret K. Offermann, Chief Executive OfficerPrepared for AIM-HI Accelerator Fund - 15 May 2020OncoSpherix is a pre-clinical small mo...See details»
Triumph Over Cancer | OncoSpherix
OncoSpherix is developing drugs that are designed to enable people with high risk and advanced cancers to have a better life. Our drugs target a common feature of nearly all cancers: the …See details»
Mission Driven Science - OncoSpherix
OncoSpherix’s focus is guided by science and motivated by medical need. 64B combined with cytotoxic chemotherapy synergistically inhibits growth of A549 lung adenocarcinoma …See details»